Insights from 2023 ASCO® Annual Meeting


 

ASCO® 2023 Insights: "Efficacy and Safety Analysis of Sacituzumab Govitecan by Trop-2 Expression and UGT1A1 Status in the TROPHY-U-01 Study for LA or mUC"

165 views
June 8, 2023
Comments 0
Login to view comments. Click here to Login